Marico (MARICO.NS) traded up 1.13 % during a 24 hours period ending at 03:04 PM Central Europe on Tuesday 27th. One Marico stock can currently be bought for about INR 776.15 on popular exchanges. Current supply of Marico stocks is 1.3 bn. Marico has a current market capitalization of INR 993.7 bn and approximately INR 975.1 mn worth of Marico was traded on exchanges in the last 24 hours. Since last month end, Marico has traded -4.68 % down. Simple moving average of last 200 days is at INR 801.64. The highest price of past 52 weeks was recorded at INR 889.1 on 07/30/2026. 52 weeks low was at INR 705.8 on 11/07/2025.

Here is how related stocks have performed in the past 24 hours:

  • Hitachi Energy India (POWERINDIA.NS) traded down -2.72 % and now trades at INR 28,395. Hitachi Energy India has a market capitalisation of INR 1.2 trillions. Hitachi Energy India has a current price to earnings ratio of 144.41.

  • Dr Reddy’s Laboratories (DRREDDY.NS) traded down -0.13 % and now trades at INR 1,233. Dr Reddy’s Laboratories has a market capitalisation of INR 1.1 trillions. Dr Reddy’s Laboratories has a current price to earnings ratio of 26.03. Dr. Reddy’s Laboratories Limited filed a 6‑K report with the U.S. Securities and Exchange Commission on 26 October 2026. The filing, submitted by the company’s headquarters in Hyderabad, India, provides an update on the group’s financial performance for the quarter and half‑year ended 30 September 2026. It includes links to the audio and video recordings of the earnings call held on 23 October 2026, and the company’s limited review reports on its unaudited consolidated and standalone financial results. The reports, issued by Deloitte Haskins & Sells LLP, confirm that the statements were prepared in accordance with Indian accounting standards and listing regulations, and that no material misstatements were identified. The filing serves to inform U.S. investors and regulators of the company’s recent financial outcomes and compliance status.

  • Indian Hotels (INDHOTEL.NS) traded up 1.76 % and now trades at INR 812.85. Current market capitalisation for Indian Hotels is INR 1.1 trillions. Current price/earnings ratio for Indian Hotels is 54.34.

  • Lenskart (LENSKART.NS) traded up 3.95 % and now trades at INR 669.2. Lenskart has a market capitalisation of INR 1.1 trillions. Foreign institutional investors increased their stake in Lenskart Solutions Ltd. during the July‑September quarter, raising holdings by 5.5 percentage points to just over 18 per cent. Domestic institutional investors also expanded their position, adding 3.25 percentage points to reach nearly 27 per cent. The company, a technology‑driven eyewear retailer, has reported a significant rise in consolidated revenue and operating profit, with margin expansion noted. Same‑store sales and eye‑test volumes grew, while the firm added a large number of new stores and entered many new towns, signalling a focus on domestic expansion. International operations have shown growth, with revenue from overseas markets increasing. Lenskart is investing in manufacturing capacity and supply‑chain integration to support further expansion and improve margins, though its capital efficiency remains below industry peers.

  • Hdfc Life Insurance (HDFCLIFE.NS) traded down -0.91 % and now trades at INR 513.6. Hdfc Life Insurance has a market capitalisation of INR 1.1 trillions. Hdfc Life Insurance has a current price to earnings ratio of 56.34. HDFC Life Insurance Co Ltd experienced a modest decline in its share price during recent market sessions, reflecting broader sectoral softness. The insurer was among several large‑cap names that slipped, contributing to a cautious mood despite overall market gains. Analysts noted that the company’s valuation had been adjusted following a recent portfolio re‑balancing by brokerage firms, which reduced its weight in recommended portfolios. While the market recovered from a four‑day losing streak, investors remained attentive to macro‑headwinds such as elevated oil prices and geopolitical uncertainties. The insurer’s performance is also being monitored in the context of impending accounting standard changes that may affect financial reporting and profit presentation for large companies. The market outlook remains mixed, with moderate upside potential balanced by structural risks.